These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 10831716

  • 1. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
    Farrell MA, McAdams HP, Herndon JE, Patz EF.
    Radiology; 2000 Jun; 215(3):886-90. PubMed ID: 10831716
    [Abstract] [Full Text] [Related]

  • 2. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 3. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
    Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P, Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.
    Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
    [Abstract] [Full Text] [Related]

  • 4. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
    Kim BT, Lee KS, Shim SS, Choi JY, Kwon OJ, Kim H, Shim YM, Kim J, Kim S.
    Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
    [Abstract] [Full Text] [Related]

  • 5. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [Abstract] [Full Text] [Related]

  • 6. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
    Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, Weder W.
    Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
    [Abstract] [Full Text] [Related]

  • 7. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X, Zhang H, Xing L, Ma H, Xie P, Zhang L, Xu X, Yue J, Sun X, Hu X, Chen M, Xu W, Chen L, Yu J.
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [Abstract] [Full Text] [Related]

  • 8. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
    Kelly RF, Tran T, Holmstrom A, Murar J, Segurola RJ.
    Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
    [Abstract] [Full Text] [Related]

  • 9. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
    Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS.
    Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
    [Abstract] [Full Text] [Related]

  • 10. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
    Taus Á, Aguiló R, Curull V, Suárez-Piñera M, Rodríguez-Fuster A, Rodríguez de Dios N, Pijuan L, Zuccarino F, Vollmer I, Sánchez-Font A, Belda-Sanchis J, Arriola E.
    Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
    [Abstract] [Full Text] [Related]

  • 11. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 12. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
    Aquino SL, Fischman AJ.
    Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
    [Abstract] [Full Text] [Related]

  • 13. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
    Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA.
    Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
    [Abstract] [Full Text] [Related]

  • 14. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
    Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.
    Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
    [Abstract] [Full Text] [Related]

  • 15. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW.
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FDG-PET in staging lung cancer: how does it change the algorithm?
    Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ.
    Lung Cancer; 2004 May; 44(2):175-81. PubMed ID: 15084382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer].
    Weber WA, Dietlein M, Hellwig D, Kirsch CM, Schicha H, Schwaiger M.
    Nuklearmedizin; 2003 Aug; 42(4):135-44. PubMed ID: 12937692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.